Evidence map›Paper›PMID 30249647›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

MAVS deficiency induces gut dysbiotic microbiota conferring a proallergic phenotype.

Emilie Plantamura, Amiran Dzutsev, Mathias Chamaillard, Sophia Djebali, Lyvia Moudombi, Lilia Boucinha, Morgan Grau, Claire Macari, David Bauché, Oana Dumitrescu and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Of Mice and MAVS-Diabetic Kidney Disease and the Leaky Gut.Journal of the American Society of Nephrology : JASN · 2022
    Article
  7. Review
  8. Implications of Gut Microbiota in Complex Human Diseases.International journal of molecular sciences · 2021
    Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 7 institutions in 4 countries.

Emilie PlantamuraCentre International de Recherche en Infectiologie, INSERM U1111-CNRS UMR5308, 69365 Lyon Cedex 07, France.
Amiran DzutsevCancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702.
Mathias ChamaillardCenter for Infection and Immunity of Lille, Institut Pasteur de Lille, INSERM U1019, F-59000 Lille, France.
Sophia DjebaliCentre International de Recherche en Infectiologie, INSERM U1111-CNRS UMR5308, 69365 Lyon Cedex 07, France.ORCID 0000-0002-0567-5387
Lyvia MoudombiCentre International de Recherche en Infectiologie, INSERM U1111-CNRS UMR5308, 69365 Lyon Cedex 07, France.
Lilia BoucinhaCentre International de Recherche en Infectiologie, INSERM U1111-CNRS UMR5308, 69365 Lyon Cedex 07, France.
Morgan GrauCentre International de Recherche en Infectiologie, INSERM U1111-CNRS UMR5308, 69365 Lyon Cedex 07, France.
Claire MacariCentre International de Recherche en Infectiologie, INSERM U1111-CNRS UMR5308, 69365 Lyon Cedex 07, France.
David BauchéCentre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, INSERM 1052, CNRS 5286, 69008 Lyon, France.
Oana DumitrescuCentre International de Recherche en Infectiologie, INSERM U1111-CNRS UMR5308, 69365 Lyon Cedex 07, France.
Jean-Philippe RasigadeCentre International de Recherche en Infectiologie, INSERM U1111-CNRS UMR5308, 69365 Lyon Cedex 07, France.
Saskia LippensInflammation Research Center, Department of Biomedical Molecular Biology, Ghent University, Flanders Institute for Biotechnology, 9000 Ghent, Belgium.
Michelina PlaterotiCentre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, INSERM 1052, CNRS 5286, 69008 Lyon, France.
Elsa KressCentre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, INSERM 1052, CNRS 5286, 69008 Lyon, France.
Annabelle CesaroCenter for Infection and Immunity of Lille, Institut Pasteur de Lille, INSERM U1019, F-59000 Lille, France.
Clovis BonduCenter for Infection and Immunity of Lille, Institut Pasteur de Lille, INSERM U1019, F-59000 Lille, France.
Ulrike RothermelChronic Inflammation and Cancer, German Cancer Research Center, 69120 Heidelberg, Germany.
Mathias HeikenwälderChronic Inflammation and Cancer, German Cancer Research Center, 69120 Heidelberg, Germany.
Gerard LinaCentre International de Recherche en Infectiologie, INSERM U1111-CNRS UMR5308, 69365 Lyon Cedex 07, France.
Azzak Bentaher-BelaaouajCentre International de Recherche en Infectiologie, INSERM U1111-CNRS UMR5308, 69365 Lyon Cedex 07, France.
Julien C MarieCentre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, INSERM 1052, CNRS 5286, 69008 Lyon, France.
Christophe CauxCentre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, INSERM 1052, CNRS 5286, 69008 Lyon, France.
Giorgio TrinchieriCancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702.
Jacqueline MarvelCentre International de Recherche en Infectiologie, INSERM U1111-CNRS UMR5308, 69365 Lyon Cedex 07, France.
Marie-Cecile MichalletCentre International de Recherche en Infectiologie, INSERM U1111-CNRS UMR5308, 69365 Lyon Cedex 07, France; marie-cecile.michallet@lyon.unicancer.fr.
Université Claude Bernard Lyon 1 · FRGerman Cancer Research Center · DEInserm · FRCentre National de la Recherche Scientifique · FRLeidos (United States) · USNational Cancer Institute · USVlaams Instituut voor Biotechnologie · BE

Funding

Role of mouse microbiome in cancer and inflammationZIABC011153 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TRINCHIERI, GIORGIO · 2009 to 2025
$22.0M
6 · The paper itself

Abstract

Prominent changes in the gut microbiota (referred to as "dysbiosis") play a key role in the development of allergic disorders, but the underlying mechanisms remain unknown. Study of the delayed-type hypersensitivity (DTH) response in mice contributed to our knowledge of the pathophysiology of human allergic contact dermatitis. Here we report a negative regulatory role of the RIG-I-like receptor adaptor mitochondrial antiviral signaling (MAVS) on DTH by modulating gut bacterial ecology. Cohousing and fecal transplantation experiments revealed that the dysbiotic microbiota of

Indexed as

Adaptor Proteins, Signal TransducingAnimalsDisease Models, AnimalDysbiosisFemaleGastrointestinal MicrobiomeHomeodomain ProteinsHypersensitivityIntestinesMiceMice, Inbred C57BLMice, KnockoutPhenotypeSignal TransductionSkin Diseases, BacterialAdaptor Proteins, Signal TransducingHomeodomain ProteinsMAVS protein, mouseRAG-1 proteinallergic skin pathologiesdysbiosisMAVSRIG-like receptors

Identifiers

PMID30249647
PMCPMC6187193
OpenAlexW2891421064

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.